PDVAC Agenda 2020: Full Value of Vaccine Assessment (FVVA) for Shigella vaccines

Overview

2020 WHO Product Development for Vaccines Advisory Committee (PDVAC) Virtual Consultation: Full Value of Vaccine Assessment (FVVA) for Shigella vaccines : 18 May 2020

CHAIR: David Kaslow

This session is to discuss the critical questions that could inform the assessment from the PDVAC perspective, and their relative importance, at this point in time.

Objectives of the meeting:

• To seek feedback on the proposed questions, to be addressed by the Shigella FVVA.
  
• To identify gaps or other questions that could be addressed as part of the Shigella FVVA.